Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James D. Crapo is active.

Publication


Featured researches published by James D. Crapo.


Experimental Lung Research | 1986

Antioxidant enzyme activity in alveolar type II cells after exposure of rats to hyperoxia

Bruce A. Freeman; Robert J. Mason; Mary C. Williams; James D. Crapo

The activity of antioxidant enzymes were measured in alveolar type II cells isolated from control and 85% oxygen-exposed rats to determine if type II cells, an oxygen-resistant lung cell type had constitutively high enzyme activities and to measure the effect of hyperoxia on these antioxidant enzyme. Type II cells were isolated from lungs of control rats and rats exposed to 85% O2 for 7 days. In whole lungs of rats exposed to 85% oxygen there is an increase in activity (per lung or per mg lung DNA) in the antioxidant enzymes CuZn superoxide dismutase, Mn superoxide dismutase, catalase, glutathione peroxidase and glucose-6-phosphate dehydrogenase. Oxygen exposure significantly increased (p less than 0.05) all type II cell antioxidant enzyme activities when expressed per mg DNA. The protein content of oxygen exposed type II cells increased 25% from (63.9 +/- 4.8 micrograms/10(6) cells to 79.6 +/- 4.2 micrograms/10(6) cells, p less than 0.05). When type II cell enzyme activities were expressed in U/mg cell protein, only CuZn superoxide dismutase and Mn superoxide dismutase increased in activity following oxygen exposure (by 43% and 28% relative to air exposed lung type II cells, respectively, p less than 0.05). This suggested that most lung cell antioxidant enzymes increased in activity following oxidant stress in proportion to increased cell mass. CuZn and Mn superoxide dismutase increased activity to an extent greater than the increase in type II cell protein content after oxygen exposure. Alveolar macrophages lavaged from control and oxygen-exposed rats were also evaluated, and they had no significant change in CuZn and Mn superoxide dismutase activities. Type II cells accounted for 10% and 17% of alveolar cells in control and oxygen treated rats. By knowing the antioxidant enzyme activities in type II cells, the total enzyme activity of whole lung and the number of type II cells in control and oxygen exposed rats from morphometric data, we calculated the percent of whole lung enzyme activity accounted for by type II cells. Type II cells accounted for a high percentage of lung glucose-6-phosphate dehydrogenase (58% in control rats, 65% in oxygen exposed rats) but a low percentage of Mn superoxide dismutase (4% in control rats, 6% in oxygen exposed rats).


Archive | 1996

Nitrosylated and nitrated superoxide oxidants and reductants

Jonathan S. Stamler; James D. Crapo; Irwin Fridovich; Brian J. Day; David S. Garvey


Archive | 2010

Oxidant scavengers for treatment of type I diabetes or type II diabetes

Jon D. Piganelli; Kathryn Haskins; Sonia C. Flores; James D. Crapo; Brian J. Day; Ronald G. Gill; Richard Gammans; Manisha Patel


Archive | 2013

Development of Manganic Porphyrin Mimetics of Superoxide Dismutase Activity

James D. Crapo; Brian J. Day; Irwin Fridovich


Archive | 1997

Methods for testing compounds for use as therapeutic antioxidants

Douglas C. Wallace; Simon Melov; James D. Crapo; Brian J. Day


Archive | 2015

biochemistryinjury in primates. I. Physiology and Aerosolized manganese SOD decreases hyperoxic

Stephen P. Kantrow; James D. Crapo; Karen E. Welty-Wolf; David Taylor; Tim Oury; Lisa M. Schaefer; Cheryl L. Fattman; Augustine M. K. Choi; Karen E. Weck; C Simon; Carlos E. O. Baleeiro; Steven E. Wilcoxen; Susan B. Morris; Theodore J. Standiford; Robert; Qiaohong Liu; John M. Wo; Mukunda B. Ray; Yan Li


Archive | 2013

Table 2, Published studies showing efficacy of metalloporphyrin antioxidant mimetics

James D. Crapo; Brian J. Day; Irwin Fridovich


Archive | 2002

Capteurs oxydants destines au traitement du diabete ou a etre utilises dans une transplantation ou a induire une tolerance immunitaire

Kathryn Haskins; Sonia C. Flores; Ronald G. Gill; James D. Crapo; Brian J. Day; Richard Gammans; Manisha Patel


Archive | 2002

Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz

Jon D. Piganelli; Kathryn Haskins; Sonia C. Flores; James D. Crapo; Brian J. Day; Ronald G. Gill; Richard Gammans; Manisha Patel


Archive | 2000

Prophirines substituees et leur utilisation therapeutique

James D. Crapo; Brian J. Day; Michael P. Trova; Polivini Jolicia F. Gauunm; Douglas Bruce Kitchen; Irwin Fridovich; Ines Batinic-Haberle

Collaboration


Dive into the James D. Crapo's collaboration.

Top Co-Authors

Avatar

Brian J. Day

Anschutz Medical Campus

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ines Batinic-Haberle

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kathryn Haskins

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ronald G. Gill

University of Colorado Denver

View shared research outputs
Researchain Logo
Decentralizing Knowledge